China's Green Path policy gives donor organs nationwide transport priority to reduce delays and improve transplant outcomes. Yet after implementation, average cold ischemia time (CIT) increased and post-transplant survival worsened. We develop a two-hospital equilibrium model with endogenous pricing, hospital heterogeneity, and urgency-based allocation to explain this paradox. The model shows that faster transport can expand the set of nonlocal organs feasible for transplantation, increasing the nonlocal share and marginal-organ use. Average CIT can therefore rise even when transport time falls for each nonlocal organ. The model also shows how pricing incentives interact with urgency thresholds and why higher-quality hospitals can attract sicker patients and more marginal organs. Using patientlevel data from two liver transplant hospitals, a regression-discontinuity-in-time design, and a provenance-free EM mixture distinguishing local from nonlocal livers, we test these predictions. We find that Green Path reduced CIT for nonlocal livers, increased transplant volume and nonlocal share, raised marginal-liver use, especially at the higher-quality hospital and among super-urgent recipients, and worsened post-transplant survival. These findings show that logistics reforms can improve perorgan transport performance while worsening observed post-transplant outcomes by changing which organs and patients enter transplantation, underscoring the need to distinguish transport gains from access expansion in policy evaluation.